Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.1659
Delayed Data
As of Aug 26
 -0.0016 / -0.96%
Today’s Change
0.06
Today|||52-Week Range
0.22
+106.09%
Year-to-Date
No recent news for Hemispherx Biopharma Inc.

Today’s Trading

Previous close0.17
Today’s open0.18
Day’s range0.16 - 0.18
Volume2,297,862
Average volume (3 months)1,104,458
Market cap$41.7M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+33.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)-32.49%
P/E ratioNM
Price/Sales142.93
Price/Book2.04

Competitors

 Today’s
change
Today’s
% change
GLMDGalmed Pharmaceutica...+0.08+2.16%
CNATConatus Pharmaceutic...-0.04-2.06%
FCSCFibrocell Science In...-0.02-2.24%
PTNPalatin Technologies...+0.02+3.93%
Data as of 3:59pm ET, 08/26/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$133.0K
Annual profit (last year)-$15.2M
Net profit margin-11,451.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Secretary &
General Counsel
Thomas Kenwood Equels
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts

Partner Offers

NextAdvisor